LAS41007

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAS41007, covering 2012-07-24 to 2015-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of LAS41007 in the Treatment of Actinic Keratosis [Phase 2]